Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Pei

Showing results (841-850 of 864) with videos related to

Pageof 87
Sort By:
Journal of Clinical Immunology|August 23, 2024
Immunophenotyping and Therapeutic Insights from Chronic Mucocutaneous Candidiasis Cases with STAT1 Gain-of-Function MutationsWei-Te Lei, Yu-Fang Lo, Miyuki Tsumura, et al.
Molecular Cancer|January 12, 2021
Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responsesYu-Pei Chen, Jia-Wei Lv, Yan-Ping Mao, et al.
BMJ (Clinical Research Ed.)|February 6, 2023
Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trialYan-Ping Mao, Shun-Xin Wang, Tian-Sheng Gao, et al.
Journal of the National Cancer Institute|October 23, 2020
A Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaYuan Lei, Ying-Qin Li, Wei Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2018
Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized TrialsYu-Pei Chen, Ling-Long Tang, Qi Yang, et al.
Seminars in Arthritis and Rheumatism|September 15, 2020
Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping reviewAdam Kilian, Yu Pei Chock, Irvin J Huang, et al.
BMJ (Clinical Research Ed.)|March 31, 2026
Medial retropharyngeal nodal region sparing radiotherapy in nasopharyngeal carcinoma: five year analysis of open label, non-inferiority, multicentre, randomised phase 3 trialShun-Xin Wang, Ya-Lan Tao, Tian-Sheng Gao, et al.
Nature Medicine|June 6, 2023
The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatmentJiawei Lv, Yuan Wei, Jian-Hua Yin, et al.
Frontiers in Microbiology|August 9, 2020
Australia: A Continent Without Native Powdery Mildews? The First Comprehensive Catalog Indicates Recent Introductions and Multiple Host Range Expansion Events, and Leads to the Re-discovery of <i>Salmonomyces</i> as a New Lineage of the ErysiphalesLevente Kiss, Niloofar Vaghefi, Kaylene Bransgrove, et al.
Cell Research|July 21, 2020
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinomaYu-Pei Chen, Jian-Hua Yin, Wen-Fei Li, et al.
Pageof 87

Showing results (841-850 of 864) with videos related to

Sort By:
Pageof 87
Journal of Clinical Immunology|August 23, 2024
Immunophenotyping and Therapeutic Insights from Chronic Mucocutaneous Candidiasis Cases with STAT1 Gain-of-Function MutationsWei-Te Lei, Yu-Fang Lo, Miyuki Tsumura, et al.
Molecular Cancer|January 12, 2021
Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responsesYu-Pei Chen, Jia-Wei Lv, Yan-Ping Mao, et al.
BMJ (Clinical Research Ed.)|February 6, 2023
Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trialYan-Ping Mao, Shun-Xin Wang, Tian-Sheng Gao, et al.
Journal of the National Cancer Institute|October 23, 2020
A Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaYuan Lei, Ying-Qin Li, Wei Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2018
Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized TrialsYu-Pei Chen, Ling-Long Tang, Qi Yang, et al.
Seminars in Arthritis and Rheumatism|September 15, 2020
Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping reviewAdam Kilian, Yu Pei Chock, Irvin J Huang, et al.
BMJ (Clinical Research Ed.)|March 31, 2026
Medial retropharyngeal nodal region sparing radiotherapy in nasopharyngeal carcinoma: five year analysis of open label, non-inferiority, multicentre, randomised phase 3 trialShun-Xin Wang, Ya-Lan Tao, Tian-Sheng Gao, et al.
Nature Medicine|June 6, 2023
The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatmentJiawei Lv, Yuan Wei, Jian-Hua Yin, et al.
Frontiers in Microbiology|August 9, 2020
Australia: A Continent Without Native Powdery Mildews? The First Comprehensive Catalog Indicates Recent Introductions and Multiple Host Range Expansion Events, and Leads to the Re-discovery of <i>Salmonomyces</i> as a New Lineage of the ErysiphalesLevente Kiss, Niloofar Vaghefi, Kaylene Bransgrove, et al.
Cell Research|July 21, 2020
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinomaYu-Pei Chen, Jian-Hua Yin, Wen-Fei Li, et al.
Pageof 87